Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Takeda Pharmaceutical Co ADR shares valued at $284,951 were purchased by Giles Richard Platford on Aug 23 ’24. At $14.94 per share, Giles Richard Platford acquired 19,073 shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, TAKEDA PHARMACEUTICAL CO LTD sold 3,703,703 shares, netting a total of over 29,999,994 in proceeds. Following the sale of shares at $8.10 each, the insider now holds 3,755,583 shares.
As published in a research note from BofA Securities on March 16, 2023, Takeda Pharmaceutical Co ADR [TAK] has been rated up from a Neutral to a Buy and the price target has been revised to $20. Analysts at Cowen upgraded the stock from ‘”a Market perform”‘ to ‘”an Outperform”‘ outlook in a report released in mid July. As of October 07, 2021, Morgan Stanley has decreased its “an Overweight” rating to a “an Equal-weight” for TAK. Earlier on April 19, 2021, JP Morgan downgraded its rating. Their new recommendation was “a Neutral” for TAK stock which previously was a “an Overweight”.
Analyzing TAK Stock Performance
During the last five days, there has been a drop of approximately -1.99%. Over the course of the year, Takeda Pharmaceutical Co ADR shares have dropped approximately -6.87%. Shares of the company reached a 52-week high of $15.08 on 08/23/24 and a 52-week low of $12.57 on 06/20/24. A 50-day SMA is recorded $14.16, while a 200-day SMA reached $13.90. Nevertheless, trading volume fell to 3.78 million shares from 1.68 million shares the previous day.
Support And Resistance Levels for Takeda Pharmaceutical Co ADR (TAK)
According to the 24-hour chart, there is a support level at 13.17, which, if violated, would cause prices to drop to 13.06. In the upper region, resistance lies at 13.44. The next price resistance is at 13.60. RSI (Relative Strength Index) is 32.45 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.24, which suggests the price will decrease in the coming days. Percent R is at 92.23%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
